Sign Up to like & get
recommendations!
2
Published in 2023 at "Advanced Materials"
DOI: 10.1002/adma.202300964
Abstract: Tumor immunotherapy based on immune checkpoint blockade (ICB) still suffers from low host response rate and non‐specific distribution of immune checkpoint inhibitors, greatly compromising the therapeutic efficiency. Herein, cellular membrane stably expressing matrix metallopeptidase 2…
read more here.
Keywords:
cell membrane;
immunotherapy;
mmp2 activated;
bto ... See more keywords